BRCA1 MUTATION CARRIER
Clinical trials for BRCA1 MUTATION CARRIER explained in plain language.
Never miss a new study
Get alerted when new BRCA1 MUTATION CARRIER trials appear
Sign up with your email to follow new studies for BRCA1 MUTATION CARRIER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail shows promise for Tough-to-Treat recurrent cancers
Disease control OngoingThis study tests two drug combinations (olaparib plus either vistusertib or capivasertib) in people with endometrial, triple-negative breast, ovarian, or related cancers that returned after prior treatment. The main goal is to find the safest dose and understand side effects. Abo…
Matched conditions: BRCA1 MUTATION CARRIER
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC
-
Diabetes drug metformin tested as breast cancer shield
Prevention OngoingThis study tests whether metformin, a common diabetes drug, can prevent breast cancer in women at high risk. Participants take metformin or a placebo for 12 months. Researchers check breast tissue samples for abnormal cells to see if the drug reduces cancer risk.
Matched conditions: BRCA1 MUTATION CARRIER
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Prevention
Last updated May 01, 2026 16:00 UTC